Sage Capital Advisors,Llc Bristol Myers Squibb CO Transaction History

Sage Capital Advisors,Llc

  • $407 Million
  • Q3 2025

A detailed history of Sage Capital Advisors,Llc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sage Capital Advisors,Llc holds 87,191 shares of BMY stock, worth $4.08 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
87,191
Previous 85,234 2.3%
Holding current value
$4.08 Million
Previous $3.95 Million 0.33%
% of portfolio
0.97%
Previous 1.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025
BUY
$43.31 - $48.98 $84,757 - $95,853
1,957 Added 2.3%
87,191 $3.93 Million
Q2 2025

Jul 03, 2025
BUY
$44.12 - $59.6 $1.42 Million - $1.92 Million
32,181 Added 60.66%
85,234 $3.95 Million
Q1 2025

Apr 04, 2025
SELL
$53.9 - $63.11 $214,845 - $251,556
-3,986 Reduced 6.99%
53,053 $3.24 Million
Q4 2024

Jan 10, 2025
BUY
$51.92 - $59.94 $29,438 - $33,985
567 Added 1.0%
57,039 $3.23 Million
Q3 2024

Oct 08, 2024
BUY
$39.66 - $51.75 $42,237 - $55,113
1,065 Added 1.92%
56,472 $2.92 Million
Q2 2024

Jul 09, 2024
SELL
$40.25 - $52.99 $96,841 - $127,493
-2,406 Reduced 4.16%
55,407 $2.3 Million
Q1 2024

Apr 15, 2024
BUY
$47.98 - $54.4 $67,555 - $76,595
1,408 Added 2.5%
57,813 $3.14 Million
Q4 2023

Jan 09, 2024
SELL
$48.48 - $57.85 $594,607 - $709,530
-12,265 Reduced 17.86%
56,405 $2.89 Million
Q3 2023

Oct 12, 2023
BUY
$57.89 - $64.73 $80,119 - $89,586
1,384 Added 2.06%
68,670 $3.99 Million
Q2 2023

Jul 12, 2023
BUY
$63.71 - $70.74 $533,698 - $592,588
8,377 Added 14.22%
67,286 $4.3 Million
Q1 2023

Apr 11, 2023
BUY
$65.71 - $74.53 $50,530 - $57,313
769 Added 1.32%
58,909 $4.08 Million
Q4 2022

Jan 19, 2023
BUY
$68.48 - $81.09 $487,029 - $576,712
7,112 Added 13.94%
58,140 $0
Q3 2022

Oct 17, 2022
SELL
$0.13 - $76.84 $220 - $130,166
-1,694 Reduced 3.21%
51,028 $3.63 Million
Q2 2022

Jul 06, 2022
SELL
$72.62 - $79.98 $4.37 Million - $4.82 Million
-60,243 Reduced 53.33%
52,722 $4.06 Million
Q1 2022

Apr 11, 2022
BUY
$61.48 - $73.72 $51,274 - $61,482
834 Added 0.74%
112,965 $8.79 Million
Q4 2021

Jan 20, 2022
BUY
$53.63 - $62.52 $1.23 Million - $1.44 Million
22,999 Added 25.8%
112,131 $7.26 Million
Q3 2021

Oct 26, 2021
BUY
$59.17 - $69.31 $48,874 - $57,250
826 Added 0.94%
89,132 $5.27 Million
Q2 2021

Jul 22, 2021
BUY
$61.91 - $67.42 $340,505 - $370,810
5,500 Added 6.64%
88,306 $5.93 Million
Q1 2021

May 04, 2021
BUY
$59.34 - $66.74 $201,637 - $226,782
3,398 Added 4.28%
82,806 $5.23 Million
Q4 2020

Feb 08, 2021
BUY
$57.74 - $65.43 $6,640 - $7,524
115 Added 0.15%
79,408 $4.89 Million
Q3 2020

Oct 29, 2020
BUY
$57.43 - $63.64 $69,375 - $76,877
1,208 Added 1.55%
79,293 $4.78 Million
Q2 2020

Jul 13, 2020
BUY
$54.82 - $64.09 $171,476 - $200,473
3,128 Added 4.17%
78,085 $4.59 Million
Q1 2020

Apr 17, 2020
BUY
$46.4 - $67.43 $541,024 - $786,233
11,660 Added 18.42%
74,957 $4.18 Million
Q4 2019

Jan 16, 2020
BUY
$49.21 - $64.19 $23,177 - $30,233
471 Added 0.75%
63,297 $4.06 Million
Q3 2019

Oct 17, 2019
SELL
$42.77 - $50.71 $53,376 - $63,286
-1,248 Reduced 1.95%
62,826 $3.19 Million
Q2 2019

Jul 31, 2019
SELL
$44.62 - $49.34 $41,675 - $46,083
-934 Reduced 1.44%
64,074 $2.82 Million
Q1 2019

Apr 23, 2019
BUY
$45.12 - $53.8 $14,799 - $17,646
328 Added 0.51%
65,008 $3.1 Million
Q4 2018

Feb 11, 2019
BUY
$48.76 - $63.23 $6,875 - $8,915
141 Added 0.22%
64,680 $3.36 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $28,643 - $32,307
519 Added 0.81%
64,539 $4.01 Million
Q2 2018

Aug 14, 2018
BUY
$50.53 - $62.98 $3.23 Million - $4.03 Million
64,020 New
64,020 $3.54 Million

Others Institutions Holding BMY

# of Institutions
2,681
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sage Capital Advisors,Llc Portfolio

Follow Sage Capital Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email